The cardiometabolic syndrome is a concept recently developed by the American Heart Association to denote the totality of risk in a patient with risk factors that may lead to or worsen chronic kidney disease or cardiovascular events. A new validated scoring system has been endorsed by AHA to better assess the short and long-term risk for these in the general population.  We will discuss this scoring system in this podcast.

The GameChanger
A new validated scoring system has incorporated factors to better determine the 10 and 30 year risk of CVD and CKD in a general population.

Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Mathew Boyd, PharmD
Clinical Pharmacist
Unity Point
 
Reference
Guidelines: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001191

Calculator: https://professional.heart.org/en/guidelines-and-statements/prevent-calculator

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the concept of the Cardiovascular-Kidney-Metabolic syndrome.
2. Discuss how the PREVENT scoring system is applied to patients.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-075-H01-P  
Initial release date: 3/4/2024
Expiration date: 3/4/2025
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram